Quarterly report pursuant to Section 13 or 15(d)

EQUITY TRANSACTIONS

v3.21.2
EQUITY TRANSACTIONS
9 Months Ended
Jun. 30, 2021
Stockholders' Equity Note [Abstract]  
EQUITY TRANSACTIONS

NOTE 6 - EQUITY TRANSACTIONS

Common stock issued for Ready Med Platform

In October 2019, the Company acquired the software platform from Collabria LLC, a related party. In exchange for these assets the Company issued 12,000,000 shares of Common stock valued at the historical cost of the asset of $0 (See Notes 2 and 7).

Preferred Stock Dividends

As of June 30, 2021 and September 30, 2020, the cumulative arrearage of undeclared dividends for Series A Preferred stock totaled $113,655 and $83,071, respectively.

Common stock issued for Conversion of C Preferred

On March 17, 2021, the holders of Series C preferred stock, converted 521,660 shares of Series C Preferred Stock into 2,608,300 shares of Common Stock.

Declaration of Stock Dividend

On April 23, 2018, the board of Directors declared a stock dividend for common stock shareholders and for certain classes of preferred stock shareholder of the Company. That each common shareholder would receive .075 shares of VoiceInterop common stock for each one (1) share of Cleartronic stock held by the shareholder, and that each shareholder of Series C and D Preferred stock shall receive .375 shares of VoiceInterop common stock for each one (1) share of Series C or Series D Preferred stock held by the shareholder.

The record date of the dividend distribution shall be defined as the first business day following an effective statement from the United States Securities and Exchange Commission ("SEC") regarding a pending S-1 filing.

On May 13, 2019 VoiceInterop filed an S-1 registration statement with the SEC which was approved on November 14, 2019. On February 14, 2020, the Company distributed 17,819,827 shares of VoiceInterop common stock to its shareholders (See Note 9). The Company recorded $225,316 to additional paid in capital for deconsolidation of VoiceInterop, Inc.